← Leaderboards
Alfredo Nicosia
Irbm P Angeletti, Spa
$1,698,454
Attributed
$1,698,454
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $833.7K · FY2006–08$1M$750K$500K$250K$0
'06
'07
'08
Funding mix
By agency
NIH$1,698,454 · 1
By mechanism
U01$1,698,454 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Adenoviruses”
- David Heimbrook · Leidos Biomedical Research, Inc.$87,846,116
- Jaap Goudsmit · Beth Israel Deaconess Medical Center$53,211,886
- Larry Arthur$34,591,506
- Dan H. Barouch · Fred Hutchinson Cancer Center$34,036,726
- William George Nelson · Johns Hopkins University$30,145,983
- Daniel F. Hoft · Saint Louis University$29,294,132
Research focus
AdenovirusesAdenovirus VectorAffectAmino AcidsAnimalsAntiviral AgentsAntiviral TherapyBaseCandidate Disease GeneCd8b1 GeneCessation Of LifeChronicChronic DiseaseClinically RelevantConceptConditionCyclic GmpDesignDoseEpidemiologic StudiesHcv VaccineHepatitis CHepatitis C VirusAcute
Grant awards (3)
Development of an Adenovirus based HCV Vaccine: preclinical safety and immunology$180,033
U01 · FY2008 · AI · contact PI
Development of an Adenovirus based HCV Vaccine: preclinical safety and immunology$833,701
U01 · FY2007 · AI · contact PI
Development of an Adenovirus based HCV Vaccine: preclinical safety and immunology$684,720
U01 · FY2006 · AI · contact PI